Trial Profile
Safety and tolerability of Dolutegravir in HIV infected patients in a Real life setting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2016
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 19 Apr 2016 New trial record
- 25 Feb 2016 Results presented at the 23rd Conference on Retroviruses and Opportunistic Infections